ArriVent BioPharma (AVBP) Q2 2025 Earnings

12MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-1.9
-1.47
-1.03
-0.6

Details

Expected EPS
-0.664
Actual EPS
-1.9
Surprise EPS
-1.24
Surprise Percent
+186.14%

Description

ArriVent BioPharma (AVBP) has reported earnings of -1.9 per share for Q2 2025.

0 Comments

Share your thoughts